Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 84.52B | 84.77B | 81.76B | 94.44B | 81.75B | 66.81B |
Gross Profit | 10.58B | 13.93B | 14.21B | 16.55B | 15.44B | 11.77B |
EBITDA | 9.88B | 7.57B | 10.81B | 12.73B | 11.69B | 8.54B |
Net Income | 3.45B | 3.33B | 3.68B | 5.36B | 5.05B | 2.98B |
Balance Sheet | ||||||
Total Assets | 67.38B | 69.88B | 66.81B | 68.28B | 63.59B | 55.31B |
Cash, Cash Equivalents and Short-Term Investments | 4.01B | 2.19B | 2.08B | 3.19B | 4.71B | 5.80B |
Total Debt | 0.00 | 24.21B | 20.83B | 20.22B | 19.02B | 18.35B |
Total Liabilities | 46.30B | 45.66B | 43.92B | 44.58B | 44.09B | 41.23B |
Stockholders Equity | 20.64B | 23.79B | 22.48B | 23.24B | 19.04B | 13.78B |
Cash Flow | ||||||
Free Cash Flow | 6.14B | 5.79B | 5.88B | 7.05B | 6.26B | 4.78B |
Operating Cash Flow | 9.00B | 8.72B | 9.26B | 10.96B | 9.99B | 7.70B |
Investing Cash Flow | -2.69B | -2.39B | -2.18B | -3.18B | -4.82B | -3.64B |
Financing Cash Flow | -5.79B | -6.35B | -6.90B | -7.41B | -6.22B | -2.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $51.43B | 13.83 | 15.65% | 4.59% | 3.37% | 8.19% | |
75 Outperform | $14.04B | 12.22 | 13.98% | 3.88% | 14.40% | 2.41% | |
73 Outperform | $52.88B | 13.33 | 14.68% | 2.48% | 0.27% | -2.64% | |
72 Outperform | $16.51B | 19.65 | 39.01% | 1.25% | 23.70% | 31.33% | |
69 Neutral | $72.24B | 12.67 | 34.96% | 7.75% | 0.94% | 9.62% | |
65 Neutral | $14.95B | 43.53 | 21.10% | ― | -0.11% | -4.28% | |
64 Neutral | $10.73B | 15.65 | 7.61% | 2.01% | 2.80% | -14.92% |